Corcept (NASDAQ:CORT) Reports Sales Below Analyst Estimates In Q3 Earnings

Biopharma company Corcept Therapeutics (NASDAQ:CORT) fell short of the markets revenue expectations in Q3 CY2025, but sales ...

Tonix Pharmaceuticals Announces Collaboration with Massachusetts General Hospital to Advance Phase 2 Clinical Trial of Dimeric Fc-modified anti-CD40L mAb, TNX-1500…

Planning to initiate an open-label Phase 2 study of TNX-1500 under an investigator-initiated IND to evaluate safety and ...
Autocar India

2017 Maruti S-Cross facelift launched at Rs 8.49 lakh

Refreshed S-Cross gets internal and external changes; continues with same 1.3L diesel engine but now gets Maruti’s smart ...
Le Lézard

Dispatch Bio Unveils First Clinical Program and Presents Data Supporting Flare Platform at Society for Immunotherapy of Cancer (SITC) 2025 Annual Meeting

Dispatch Bio, a biotechnology company developing a universal treatment for solid tumors, today announced preclinical data supporting its first therapeutic program planned to enter the clinic, DISP-10, ...